This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arthur, M.
Right arrow Articles by Courvalin, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arthur, M.
Right arrow Articles by Courvalin, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 1999, p. 1875-1880, Vol. 43, No. 8
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Moderate-Level Resistance to Glycopeptide LY333328 Mediated by Genes of the vanA and vanB Clusters in Enterococci

Michel Arthur,1,dagger Florence Depardieu,1,* Peter Reynolds,2 and Patrice Courvalin1

Unité des Agents Antibactériens, Institut Pasteur, 75724 Paris, Cedex 15, France,1 and Department of Biochemistry, University of Cambridge, Cambridge, CB2 1 QW, United Kingdom2

Received 8 March 1999/Returned for modification 23 April 1999/Accepted 1 June 1999

Three of five natural plasmids carrying a wild-type vanA gene cluster did not confer LY333328 glycopeptide resistance on Enterococcus faecalis JH2-2 (MIC = 2 µg/ml). The two remaining plasmids conferred resistance to the drug (MIC, 8 µg/ml). The vanB gene cluster did not confer resistance to LY333328, since this antibiotic was not an inducer. Mutations in the vanSB sensor gene that allowed induction by teicoplanin or constitutive expression of the vanB cluster led to LY333328 resistance (MIC, 8 to 16 µg/ml). Overproduction of the VanH, VanA, and VanX proteins for D-alanyl-D-lactate (D-Ala-D-Lac) synthesis and D-Ala-D-Ala hydrolysis was sufficient for resistance to LY333328 (MIC, 16 µg/ml). Mutations in the host D-Ala:D-Ala ligase contributed to LY333328 resistance in certain VanA- and VanB-type strains, but the MICs of the antibiotic did not exceed 16 µg/ml. Addition of D-2-hydroxybutyrate in the culture medium of mutants that did not produce the VanH D-lactate dehydrogenase led to incorporation of this D-2-hydroxy acid at the C-terminal ends of the peptidoglycan precursors and to LY333328 resistance (MIC, 64 µg/ml). The vanZ gene of the vanA cluster conferred resistance to LY333328 (MIC, 8 µg/ml) by an unknown mechanism. These data indicate that VanA- and VanB-type enterococci may acquire moderate-level resistance to LY333328 (MIC <=  16 µg/ml) in a single step by various mechanisms.

* Corresponding author. Mailing address: Unité des Agents Antibactériens, Institut Pasteur, 28, rue du Dr. Roux, 75724 Paris Cedex 15, France. Phone: (33) (1) 45 68 83 21. Fax: (33) (1) 45 68 83 19. E-mail: fdepard{at}pasteur.fr.

dagger Present address: Biochimie Structurale et Cellulaire, CNRS EP1088, Université Paris-Sud, 91405 Orsay Cedex, France.

Antimicrobial Agents and Chemotherapy, August 1999, p. 1875-1880, Vol. 43, No. 8
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., Courvalin, P. (2007). Modes and Modulations of Antibiotic Resistance Gene Expression. Clin. Microbiol. Rev. 20: 79-114 [Abstract] [Full Text]  
  • Goffin, P., Deghorain, M., Mainardi, J.-L., Tytgat, I., Champomier-Verges, M.-C., Kleerebezem, M., Hols, P. (2005). Lactate Racemization as a Rescue Pathway for Supplying D-Lactate to the Cell Wall Biosynthesis Machinery in Lactobacillus plantarum. J. Bacteriol. 187: 6750-6761 [Abstract] [Full Text]  
  • Depardieu, F., Reynolds, P. E., Courvalin, P. (2003). VanD-Type Vancomycin-Resistant Enterococcus faecium 10/96A. Antimicrob. Agents Chemother. 47: 7-18 [Abstract] [Full Text]  
  • Coyle, E. A., Rybak, M. J. (2001). Activity of Oritavancin (LY333328), an Investigational Glycopeptide, Compared to That of Vancomycin against Multidrug-Resistant Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model. Antimicrob. Agents Chemother. 45: 706-709 [Abstract] [Full Text]  
  • Arthur, M., Quintiliani, R. Jr. (2001). Regulation of VanA- and VanB-Type Glycopeptide Resistance in Enterococci. Antimicrob. Agents Chemother. 45: 375-381 [Full Text]  
  • Lefort, A., Saleh-Mghir, A., Garry, L., Carbon, C., Fantin, B. (2000). Activity of LY333328 Combined with Gentamicin In Vitro and in Rabbit Experimental Endocarditis Due to Vancomycin-Susceptible or -Resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 44: 3017-3021 [Abstract] [Full Text]  
  • Zeckel, M. L., Preston, D. A., Allen, B. S. (2000). In Vitro Activities of LY333328 and Comparative Agents against Nosocomial Gram-Positive Pathogens Collected in a 1997 Global Surveillance Study. Antimicrob. Agents Chemother. 44: 1370-1374 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»